Category Archives: Practice News

The Brain’s Hypothalamic Stem Cells: The Primary Driver Of Aging?

In his latest podcast, Dr. Gladden sits with our primary investigator Dr. Sheldon Jordan to discuss brain health and optimization. Listen to learn more about Dr. Jordan’s cutting edge neuro-imaging , and how it can be used as a tool to better understand, and potential reverse, the aging process. Click the play button below to… Read More

Can 6 Weeks of Meditation Change Your Brain?

At The Regenesis Project, we use cutting edge neuro-imaging to better understand brain function. In this video, Dr. Jordan and Victoria Venkatraman partnered with Buzzfeed and Goodful to see how 6 weeks of meditation affects brain function. Check out the final results! https://youtu.be/GNN-a8Ah0qg?t=830 Key takeaways: Advanced MRI (fMRI) can show how the brain is working… Read More

Redefining Medicine with Special Guest Dr. Sheldon Jordan

Sheldon Jordan, MD is a clinical associate professor of neurology at UCLA and USC. He has a private practice in Santa Monica, California. He has taught two interventional programs at UCLA and helped establish the stroke service at UCLA and Providence Saint John’s Health Center.  He has authored numerous books and journal articles, and he lectures nationally and… Read More

Sheldon Jordan MD will lead the A4M Brain Health Summit on June 26 and 27

Join Dr. Jordan and the leaders in regenerative medicine to learn about how age-related vulnerabilities can cause a brain to fail, how to optimize brain health, and how we may be able to reprogram the biological clock. Neurologist Sheldon Jordan will be leading the exciting lineup of experts at the A4M Brain Health Summit on… Read More

How to Select a Clinical Trial for Alzheimer’s or Parkinson’s Disease

While successful treatments for Alzheimer’s Disease and Dementia already exist, the future of clinical trials and the pursuit of finding specific remedies remains confusing. It is essential for potential clinical trial participants to know how to determine if participation in a particular trial is going to be worthwhile. Over the past ten to twenty years,… Read More

Brain Toxins, Dementia and the Tap Water Dilemma

It doesn’t rain often in Los Angeles. When it does rain, it can be torrential. After one such deluge, a casual walk along the beach can present quite the surprise. The normally sparkling surf is replaced with a dense brownish froth stretching out to sea as if we are living in a B Level Horror… Read More

Why are your Hands Numb?

Carpal Tunnel Syndrome, Cervical Radiculopathy, Ulnar Neuropathy and Thoracic Outlet Syndrome all result in hand numbness. Proper diagnosis is essential in choosing effective treatment. Pins and needles, electrical buzzing and deadness are all descriptions of the sensation people feel when their hands go numb. Up to twenty percent of working people experience on and off… Read More

Can We Reset The Grim Reaper™ Clock?

Pap was 86 years old. He spent most of his life working on his farm, driving his tractor and feeding his chickens. He worked every day except Sunday when he went to church. He lived in a barter society in Western Pennsylvania, where he traded his eggs for his neighbor’s homemade salami that he strapped… Read More

Is Intermittent Fasting Good for Your Brain Health?

There has been much buzz in recent years regarding a popular dieting strategy– intermittent fasting. Despite the common belief that intermittent fasting is new, this diet has actually been proven and in practice for hundreds of years. Many swear by its caloric restriction methods, saying that this diet can help with weight loss, diabetes mellitus,… Read More

The Regenesis Project Investigates a New Treatment Possibility for Dementia, Alzheimer’s and Parkinson’s Disease

A recent study from The Regenesis Project demonstrates bosutinib may be a treatment option for patients with neurodegenerative conditions including Alzheimer’s and Parkinson’s disease. SANTA MONICA, Calif., Oct. 6, 2020 /PRNewswire/ — The pursuit of an effective therapeutic intervention for dementia has inspired interest in the class of medications known as tyrosine kinase inhibitors (TKIs). TKIs demonstrate potential… Read More